Texas Permanent School Fund’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,814
| Closed | -$1.63M | – | 1242 |
|
|
2024
Q1 | $1.63M | Buy |
47,814
+619
| +1% | +$18.4K | 0.01% | 1154 |
|
|
2023
Q4 | $1.37M | Buy |
47,195
+830
| +2% | +$22K | 0.01% | 1207 |
|
|
2023
Q3 | $1.28M | Sell |
46,365
-1,600
| -3% | -$48.7K | 0.01% | 1155 |
|
|
2023
Q2 | $1.44M | Sell |
47,965
-514
| -1% | -$18K | 0.01% | 1122 |
|
|
2023
Q1 | $1.76M | Buy |
48,479
+12,136
| +33% | +$467K | 0.02% | 1023 |
|
|
2022
Q4 | $1.3M | Sell |
36,343
-2,133
| -6% | -$74.1K | 0.02% | 990 |
|
|
2022
Q3 | $1.3M | Sell |
38,476
-130
| -0.3% | -$4.23K | 0.02% | 969 |
|
|
2022
Q2 | $1.12M | Buy |
38,606
+903
| +2% | +$25.9K | 0.02% | 1070 |
|
|
2022
Q1 | $1.22M | Sell |
37,703
-638
| -2% | -$19.6K | 0.02% | 1099 |
|
|
2021
Q4 | $1.12M | Sell |
38,341
-973
| -2% | -$29.5K | 0.01% | 1171 |
|
|
2021
Q3 | $1.05M | Sell |
39,314
-197
| -0.5% | -$5.29K | 0.01% | 1197 |
|
|
2021
Q2 | $1.22M | Sell |
39,511
-27
| -0.1% | -$828 | 0.01% | 1160 |
|
|
2021
Q1 | $1.03M | Sell |
39,538
-2,765
| -7% | -$77.3K | 0.01% | 1200 |
|
|
2020
Q4 | $1.06M | Sell |
42,303
-6,892
| -14% | -$148K | 0.01% | 1140 |
|
|
2020
Q3 | $1.02M | Buy |
49,195
+7,685
| +19% | +$174K | 0.01% | 1100 |
|
|
2020
Q2 | $986K | Sell |
41,510
-3,100
| -7% | -$68.5K | 0.02% | 1045 |
|
|
2020
Q1 | $803K | Buy |
44,610
+8,725
| +24% | +$183K | 0.01% | 1053 |
|
|
2019
Q4 | $851K | Buy |
35,885
+186
| +0.5% | +$4.52K | 0.01% | 1167 |
|
|
2019
Q3 | $981K | Buy |
35,699
+147
| +0.4% | +$4.36K | 0.02% | 1072 |
|
|
2019
Q2 | $1.18M | Buy |
35,552
+28
| +0.1% | +$959 | 0.02% | 986 |
|
|
2019
Q1 | $1.25M | Buy |
35,524
+1,328
| +4% | +$49.4K | 0.02% | 967 |
|
|
2018
Q4 | $1.14M | Buy |
34,196
+1,343
| +4% | +$57.8K | 0.02% | 936 |
|
|
2018
Q3 | $1.65M | Sell |
32,853
-577
| -2% | -$28.5K | 0.02% | 871 |
|
|
2018
Q2 | $2M | Sell |
33,430
-688
| -2% | -$35.6K | 0.03% | 764 |
|
|
2018
Q1 | $1.56M | Sell |
34,118
-533
| -2% | -$22.2K | 0.02% | 872 |
|
|
2017
Q4 | $1.38M | Sell |
34,651
-2,362
| -6% | -$93.3K | 0.02% | 965 |
|
|
2017
Q3 | $1.48M | Buy |
37,013
+302
| +0.8% | +$13.1K | 0.02% | 958 |
|
|
2017
Q2 | $1.58M | Buy |
36,711
+423
| +1% | +$15.1K | 0.02% | 906 |
|
|
2017
Q1 | $1.14M | Buy |
36,288
+178
| +0.5% | +$4.77K | 0.01% | 1053 |
|
|
2016
Q4 | $912K | Sell |
36,110
-1,605
| -4% | -$35.9K | 0.01% | 1131 |
|
|
2016
Q3 | $933K | Buy |
37,715
+11,263
| +43% | +$255K | 0.01% | 1111 |
|
|
2016
Q2 | $539K | Sell |
26,452
-941
| -3% | -$16.7K | 0.01% | 1289 |
|
|
2016
Q1 | $418K | Sell |
27,393
-923
| -3% | -$12K | 0.01% | 1352 |
|
|
2015
Q4 | $381K | Buy |
28,316
+282
| +1% | +$4.36K | ﹤0.01% | 1375 |
|
|
2015
Q3 | $393K | Buy |
28,034
+3,654
| +15% | +$67.9K | 0.01% | 1367 |
|
|
2015
Q2 | $414K | Buy |
+24,380
| New | +$347K | ﹤0.01% | 1392 |
|
Other funds holding SUPN
AC
PCH
SIMG
Texas Permanent School Fund's SUPN Position: Q2 2024 in Review
Texas Permanent School Fund sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 47,814 shares — an estimated $1.63M sold.
Texas Permanent School Fund first reported a position in SUPN in Q2 2015 and held it in 36 quarters. The position peaked at $2M in Q2 2018. 244 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.
- Texas Permanent School Fund reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Texas Permanent School Fund sold 47,814 Supernus Pharmaceuticals shares in Q2 2024, an estimated $1.63M.
- Texas Permanent School Fund first reported a position in Supernus Pharmaceuticals in Q2 2015 and held it in 36 quarters.
- Texas Permanent School Fund's Supernus Pharmaceuticals position peaked at $2M in Q2 2018.
- 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.
Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.